Insider Trading & Ownership - Karyopharm Therapeutics Inc. (KPTI)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Karyopharm Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-08-04
Sale		 2022-08-05
4:08 pm		 Karyopharm Therapeutics Inc. KPTI Paulson Richard A.
President and CEO		 2,314 $4.48 $10,367 626,477
(Direct)		 View
2022-07-08
Sale		 2022-07-11
4:18 pm		 Karyopharm Therapeutics Inc. KPTI Paulson Richard A.
President and CEO		 2,115 $5.1762 $10,948 628,791
(Direct)		 View
2022-06-13
Sale		 2022-06-14
7:25 pm		 Karyopharm Therapeutics Inc. KPTI Cheng Sohanya Roshan
Chief Commercial Officer		 1,551 $5.2062 $8,075 89,949
(Direct)		 View
2022-06-08
Sale		 2022-06-10
5:20 pm		 Karyopharm Therapeutics Inc. KPTI PAKIANATHAN DEEPIKA
Director		 538,784 $6.3751 $3,434,798 16,673
(Indirect)		 View
2022-06-07
Sale		 2022-06-08
4:23 pm		 Karyopharm Therapeutics Inc. KPTI Paulson Richard A.
President and CEO		 2,542 $5.7602 $14,642 630,906
(Direct)		 View
2022-06-03
Sale		 2022-06-06
5:40 pm		 Karyopharm Therapeutics Inc. KPTI Mason Michael
EVP, CFO, Treasurer		 601 $6.0401 $3,630 138,509
(Direct)		 View
2022-05-04
Sale		 2022-05-05
4:08 pm		 Karyopharm Therapeutics Inc. KPTI Paulson Richard A.
President and CEO		 28,502 $6.228 $177,509 633,448
(Direct)		 View
2022-02-28
Sale		 2022-03-02
3:34 pm		 Karyopharm Therapeutics Inc. KPTI Frenkel Ran
EVP, Chief Dev. Officer		 1,663 $10.24 $17,025 258,290
(Direct)		 View
2022-02-28
Sale		 2022-03-02
3:33 pm		 Karyopharm Therapeutics Inc. KPTI Mason Michael
EVP, CFO & Treasurer		 2,398 $10.24 $24,550 250,710
(Direct)		 View
2022-02-28
Sale		 2022-03-02
3:20 pm		 Karyopharm Therapeutics Inc. KPTI Shacham Sharon
Chief Scientific Officer		 12,452 $10.24 $127,477 1,638,888
(Indirect
Direct)		 View
2022-02-28
Sale		 2022-03-02
3:18 pm		 Karyopharm Therapeutics Inc. KPTI Kauffman Michael
Director		 12,452 $10.24 $127,477 1,638,888
(Indirect
Direct)		 View
2022-02-17
Sale		 2022-02-22
4:19 pm		 Karyopharm Therapeutics Inc. KPTI Shah Jatin
EVP, Chief Medical Officer		 1,306 $12.12 $15,833 129,450
(Direct)		 View
2022-02-17
Sale		 2022-02-22
4:16 pm		 Karyopharm Therapeutics Inc. KPTI Frenkel Ran
EVP, Chief Dev. Officer		 2,929 $12.12 $35,509 101,703
(Direct)		 View
2022-02-17
Sale		 2022-02-22
4:15 pm		 Karyopharm Therapeutics Inc. KPTI Shacham Sharon
Chief Scientific Officer		 18,167 $12.12 $220,246 1,603,340
(Indirect
Direct)		 View
2022-02-17
Sale		 2022-02-22
4:14 pm		 Karyopharm Therapeutics Inc. KPTI Kauffman Michael
Director		 18,167 $12.12 $220,246 1,603,340
(Indirect
Direct)		 View
2022-02-07
Sale		 2022-02-09
5:27 pm		 Karyopharm Therapeutics Inc. KPTI Shah Jatin
EVP, Chief Medical Officer		 1,704 $9.862 $16,805 130,756
(Direct)		 View
2022-02-07
Sale		 2022-02-09
5:26 pm		 Karyopharm Therapeutics Inc. KPTI Frenkel Ran
EVP, Chief Dev. Officer		 1,991 $9.862 $19,635 104,632
(Direct)		 View
2022-02-07
Sale		 2022-02-09
5:25 pm		 Karyopharm Therapeutics Inc. KPTI Mason Michael
EVP, CFO & Treasurer		 3,947 $9.862 $38,925 53,308
(Direct)		 View
2022-02-07
Sale		 2022-02-09
5:24 pm		 Karyopharm Therapeutics Inc. KPTI Kauffman Michael
Director		 13,471 $9.862 $132,851 1,621,507
(Indirect
Direct)		 View
2022-02-07
Sale		 2022-02-09
5:22 pm		 Karyopharm Therapeutics Inc. KPTI Shacham Sharon
Chief Scientific Officer		 13,471 $9.862 $132,851 1,621,507
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-08-31
Option Award		 2022-09-01
9:00 pm		 N/A
2032-08-30		 Karyopharm Therapeutics Inc. KPTI Cheng Sohanya Roshan
EVP & Chief Commercial Officer		 75,000 $0 164,949
(Direct)		 View
2022-08-31
Option Award		 2022-09-01
8:59 pm		 N/A
2032-08-30		 Karyopharm Therapeutics Inc. KPTI Mason Michael
EVP, CFO & Treasurer		 75,000 $0 213,509
(Direct)		 View

Ownership		 2022-08-19
4:15 pm		 N/A
N/A		 Karyopharm Therapeutics Inc. KPTI Poulton Stuart
EVP, Chief Development Officer		 0 $0 180,000
(Direct)		 View
2022-08-11
Exercise		 2022-08-15
08:05 am		 N/A
N/A		 Karyopharm Therapeutics Inc. KPTI Greene Barry E
Director		 7,576 $1.485 13,606
(Direct)		 View
2022-08-11
Exercise		 2022-08-15
08:05 am		 N/A
2023-01-20		 Karyopharm Therapeutics Inc. KPTI Greene Barry E
Director		 7,576 $0 13,606
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:12 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI Schor Chen
Director		 23,900 $0 23,900
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:11 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI PAKIANATHAN DEEPIKA
Director		 23,900 $0 23,900
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:09 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI Oliger Christy J.
Director		 23,900 $0 23,900
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:07 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI Mirza Mansoor Raza
Director		 23,900 $0 23,900
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:06 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI Honig Peter
Director		 10,995 $0 10,995
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:03 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI BOHLIN GAREN G
Director		 23,900 $0 23,900
(Direct)		 View
2022-05-19
Option Award		 2022-05-20
4:02 pm		 N/A
2032-05-18		 Karyopharm Therapeutics Inc. KPTI Greene Barry E
Director		 23,900 $0 23,900
(Direct)		 View
2022-04-29
Option Award		 2022-05-02
5:01 pm		 N/A
2032-04-28		 Karyopharm Therapeutics Inc. KPTI Rangwala Reshma
EVP & Chief Medical Officer		 165,000 $0 165,000
(Direct)		 View
2022-03-29
Option Award		 2022-03-31
4:17 pm		 N/A
2032-03-28		 Karyopharm Therapeutics Inc. KPTI Shacham Sharon
Chief Scientific Officer		 150,000 $0 1,761,888
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:34 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Frenkel Ran
EVP, Chief Dev. Officer		 158,250 $0 258,290
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:33 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Mason Michael
EVP, CFO & Treasurer		 199,800 $0 250,710
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:20 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Shacham Sharon
Chief Scientific Officer		 48,000 $0 1,638,888
(Indirect)		 View
2022-02-28
Option Award		 2022-03-02
3:18 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Kauffman Michael
Director		 48,000 $0 1,638,888
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:15 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Mitchener Stephen
SVP, Chief Business Officer		 106,650 $0 109,946
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:15 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Cheng Sohanya Roshan
Chief Commercial Officer		 192,000 $0 199,500
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:14 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Paulson Richard A.
President and CEO		 648,750 $0 1,021,950
(Direct)		 View
2022-02-28
Option Award		 2022-03-02
3:14 pm		 N/A
2032-02-27		 Karyopharm Therapeutics Inc. KPTI Mano Michael
SVP, General Counsel&Secretary		 144,000 $0 144,000
(Direct)		 View
2021-12-03
Option Award		 2021-12-07
10:37 am		 N/A
2031-12-02		 Karyopharm Therapeutics Inc. KPTI Honig Peter
Director		 47,800 $0 47,800
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, 5, Next